Catalogue of EQ-5D Scores for the United Kingdom

Patrick W. Sullivan, Julia F. Slejko, Mark J. Sculpher and Vahram Ghushchyan

Medical Decision Making, 2011, vol. 31, issue 6, 800-804

Abstract: Background . The National Institute for Health and Clinical Excellence (NICE) has issued guidance on cost-effectiveness analyses, suggesting that preference-based health-related quality of life (HRQL) weights or utilities be based on UK community preferences, preferably using the EQ-5D; ideally all analyses would use the same system for deriving HRQL weights, to encourage consistency and comparability across analyses. Development of a catalogue of EQ-5D scores for a range of health conditions based on UK preferences would help achieve many of these goals. Objective . To provide a UK-based catalogue of EQ-5D index scores. Methods . Methods were consistent with the previously published catalogue of EQ-5D scores for the US. Community-based UK preferences were applied to EQ-5D descriptive questionnaire responses in the US-based Medical Expenditure Panel Survey (MEPS). Ordinary least squares (OLS), Tobit, and censored least absolute deviations (CLAD) regression methods were used to estimate the ‘marginal disutility’ of each condition controlling for covariates. Results . Pooled MEPS files (2000-2003) resulted in 79,522 individuals with complete EQ-5D scores. Marginal disutilities for 135 chronic ICD-9 and 100 CCC codes are provided. Unadjusted descriptive statistics including mean, median, 25th and 75th percentiles are also reported. Conclusion . This research provides community-based EQ-5D index scores for a wide variety of chronic conditions that can be used to estimate QALYs in cost-effectiveness analyses in the UK. Although using EQ-5D questionnaire responses from the US-based MEPS is less than ideal, the estimates approximate HRQL guidelines by NICE and provide an easily accessible“off-the-shelf†resource for cost-effectiveness and publichealth applications.

Keywords: cost utility analysis; cost-effectiveness analysis; economic aspects of disease; pharmacoeconomics; productivity loss; decision analysis; probabilistic sensitivity analysis; simulation methods; Monte Carlo methods (search for similar items in EconPapers)
Date: 2011
References: View complete reference list from CitEc
Citations: View citations in EconPapers (8)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X11401031 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:31:y:2011:i:6:p:800-804

DOI: 10.1177/0272989X11401031

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().